JPS60186297A - Removal of nad+ activation inhibitor - Google Patents

Removal of nad+ activation inhibitor

Info

Publication number
JPS60186297A
JPS60186297A JP4143684A JP4143684A JPS60186297A JP S60186297 A JPS60186297 A JP S60186297A JP 4143684 A JP4143684 A JP 4143684A JP 4143684 A JP4143684 A JP 4143684A JP S60186297 A JPS60186297 A JP S60186297A
Authority
JP
Japan
Prior art keywords
nad
activity
enzyme
inhibitors
remove
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4143684A
Other languages
Japanese (ja)
Other versions
JPH0452117B2 (en
Inventor
Takeshi Fujita
剛 藤田
Yoshiyuki Yamamoto
山本 芳行
Yoshiki Yamagata
山縣 孝樹
Yasuo Suzuki
康生 鈴木
Isamu Kokawara
高河原 勇
Katsumi Fujii
克美 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oriental Yeast Co Ltd
Original Assignee
Oriental Yeast Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oriental Yeast Co Ltd filed Critical Oriental Yeast Co Ltd
Priority to JP4143684A priority Critical patent/JPS60186297A/en
Publication of JPS60186297A publication Critical patent/JPS60186297A/en
Publication of JPH0452117B2 publication Critical patent/JPH0452117B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:NAD<+> containing substance inhibiting NAD<+> activity is brought into contact with NAD<+>-dependent enzymes in a buffer solution to remove the substance, whereby high-purity and high-activity NAD<+> is obtained which can be used in clinical assays. CONSTITUTION:In the preparation of nicotin amide-adenine dinucleotide (NAD<+>) the NAD<+> powder containing NAD<+> activity inhibitors is dissolved in a phosphate buffer to adjust its pH to 6.0. Then, an NAD<+>-depending enzyme (lactic acid dehydrogenase) is added to effect reactions and the reaction mixture is subjected to ultrafiltration to remove the NAD<+>-depending enzyme to give the objective high-activity NAD<+> free from inhibitors.

Description

【発明の詳細な説明】 本発明は高活性のニコチンアミドアデニンジヌクレオタ
イド(NAI)十という)の製造法に関するものである
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing highly active nicotinamide adenine dinucleotide (NAI).

更に詳細には、NAI)+中に混在するNAD+活性阻
害物質を除去することによって高活性のNAD+金製造
する方法に関するものである。
More specifically, the present invention relates to a method for producing highly active NAD+ gold by removing NAD+ activity inhibitors mixed in NAI)+.

一般に、NAD+は生化学研究や臨床検査の分野で今日
最も広く使用されている助酵素で25って、純度が高く
、高活性のものが望まれるものである。
In general, NAD+ is the coenzyme most widely used today in the fields of biochemical research and clinical testing25, and it is desired to have high purity and high activity.

しかしながら、NAD+標品においても(7ばしば活性
の低下がみられるのである。
However, even in NAD+ preparations (7), a decrease in activity is often observed.

活性の低下したNAD+標品について詳細に検討すると
、NAD十活性を阻害する物質が認められるのである。
A detailed study of NAD+ preparations with reduced activity reveals substances that inhibit NAD+ activity.

NAD+活性阻害物質について検討しようとしても、分
離精製がきわめて困難なため現在阻害物質の構造並びに
性質については全く不明な状態である。
Even if we try to study NAD+ activity inhibitors, the structure and properties of the inhibitors are currently completely unknown because separation and purification is extremely difficult.

しかし、NAD+標品にNAD+活性阻害物質が含まれ
ると、NAD+標品を使用する酵素活性測定の精度や酵
素反応解析に大きな影響を与えるために、NAD+活性
阻害物質は必ず除去しなければならないのである。NA
D十活性阻害物質の物性そのものが不明であるために、
該物質の分離法の手がかりすらつかめていないの力を現
状である。
However, if NAD+ activity inhibitors are contained in NAD+ preparations, they must be removed, as this will have a significant impact on the accuracy of enzyme activity measurements and enzyme reaction analysis using NAD+ preparations. be. NA
Since the physical properties of the D10 activity inhibitor are unknown,
At present, we do not even have a clue as to how to separate this substance.

本発明者らは、NAI)十標品からNAD÷活性阻害物
質を除去するために鋭意研究したところ、NAD ”活
性阻害物質はNAD十依存性酵素に吸着され、NAD+
から分離されること全知ったのである。
The present inventors conducted extensive research to remove NAD ÷ activity inhibitor from NAI) specimens, and found that NAD'' activity inhibitor was adsorbed to NAD-dependent enzyme, and NAD +
I knew everything about being separated from the world.

本発明は、NAD+活性阻害物質を含有するNAD +
とNAD4°依存性酵素の一棟もしくは二種以上とを緩
衝液中で一触は1て、NAI)+に含有されるN人り+
活性阻害物質を除去することを特徴とするNAD +活
性阻害物質除去不法である。
The present invention provides NAD + containing an NAD + activity inhibitor.
and one or more types of NAD4°-dependent enzymes in a buffer solution, the amount of N contained in NAI)+ is reduced.
It is illegal to remove NAD + activity inhibitors, which is characterized by removing activity inhibitors.

本発明において、NAD+依存性酵素としては乳酸脱水
素酵素(LDH)、アルコール脱水酵素(A I) H
)、リンゴ酸脱水素酵(MDH)、ソルビトール脱水素
酵素(S D [()、グルタミン酸脱水素酵素(ol
Dtl)などがあげられるが、L D Hが最も好まし
い。
In the present invention, NAD+ dependent enzymes include lactate dehydrogenase (LDH) and alcohol dehydrogenase (A I) H
), malate dehydrogenase (MDH), sorbitol dehydrogenase (S D [(), glutamate dehydrogenase (ol
Dtl), etc., but LDH is most preferred.

本発明にひいては、NAD 活性阻害物質を含有するN
AJ)+標品を適当な緩衝液中でLDHなどと共存させ
ると、阻害物質は急速にLDHなどに吸着され、NAJ
)4−’に回収することによって容易に阻6害物質ケ全
く含有しないNAD+を調製することができる。ここで
用いる緩衝液の種類としては、通常酵素反応に使用され
る緩衝液であればいずれでもよい。具体的には、リン酸
、トリス−塩酸、トリエタノールアミン−塩酸、ヒスチ
ジン−塩酸、グリシルグリシン、グツド緩衝液などがあ
る。緩衝液の濃度は10mMから500 mMいずれで
もよく、好ましくは50 mMから208 mMである
According to the present invention, N containing an NAD activity inhibitor
When the AJ) + preparation is allowed to coexist with LDH etc. in an appropriate buffer solution, the inhibitory substance is rapidly adsorbed to LDH etc. and the NAJ
) 4-', NAD+ containing no inhibitory substances can be easily prepared. The type of buffer used here may be any buffer as long as it is normally used in enzyme reactions. Specific examples include phosphoric acid, Tris-hydrochloric acid, triethanolamine-hydrochloric acid, histidine-hydrochloric acid, glycylglycine, and Gud buffer. The concentration of the buffer solution may be anywhere from 10mM to 500mM, preferably from 50mM to 208mM.

また緩衝液の聞け5.5から90でよ5く、好ましくけ
ろ、0からZ5である。
The strength of the buffer solution is preferably 5.5 to 90, preferably 0 to Z5.

また、NAD+依存性酵素としてはいずれの種類でも、
いずれの給源のものでもよい。L D Hの給源として
けうざぎ筋肉、ブタ心臓、ブタ筋肉、牛心臓、牛筋肉な
どの動物給源やロイコノストック、メヒンテロイデス、
高r品菌などの細菌給(IIちるいは植物給源などがあ
るが、いずれの給源からのI、D)(も使用できる。ま
゛た使用する酵素は溶液状態あるいは固定化状態いずれ
の形態でもよいが、NAD+標品の回収には固定化状態
のほうがより好、ましい。
In addition, any type of NAD+ dependent enzyme,
It can be from any source. As sources of LDH, animal sources such as rabbit muscle, pig heart, pig muscle, bovine heart, bovine muscle, leuconostoc, mehinteroides,
Bacterial sources such as high-quality bacteria (II, plant sources, etc., but I, D) from any source can be used.Also, the enzyme used can be in either solution or immobilized form. However, the immobilized state is more preferable for recovering the NAD+ specimen.

酵素の固定化去りこは共佇結合法、イオン結庁法、物理
的吸M法、架橋法、包括法などがあり、一方、固定化担
体としては、ヒルロース、アガロース、デキストランな
どの多糖類、多孔性がシス、ポリアクリルアミド、カラ
ギーナン、ポリウレタンなどがあるがいずれの方法、し
よび1°は体でもよい。
Enzyme immobilization methods include the co-binding method, ion binding method, physical absorption method, cross-linking method, and entrapment method.On the other hand, immobilization carriers include polysaccharides such as hillulose, agarose, and dextran. The porosity may be cis, polyacrylamide, carrageenan, polyurethane, etc., but any method may be used, and 1° may be used.

NAIL’とNAI)+依存性酵素は緩衝液中で接触ざ
すられるが、その接触反応昌度は2パCから40℃いず
れでもよく、好ましくは2℃から10℃でちる。
NAIL' and NAI)+-dependent enzymes are brought into contact in a buffer solution, and the contact reaction temperature may be anywhere from 2°C to 40°C, preferably at 2°C to 10°C.

この処理によってNAD ’−活性阻害物質は酵素に吸
着式れるので、酵素を分離すれば高活性のNAI)+?
r−得ることができる。
Through this treatment, NAD'-activity inhibitors are adsorbed onto the enzyme, so if the enzyme is separated, highly active NAI)+?
r- can be obtained.

酵素が固定化されている場合は、これ全カラムeこりめ
、NAD+標品をぽ汀する緩衝液を流ド(7、強中でN
AI)+活性阻害物質を酵素に吸着させて商店+’tの
NAI)”i直)妾f種ることかできる。
If the enzyme is immobilized, drain the entire column with a buffer solution that retains the NAD+ sample (7.
AI) + activity inhibitors can be adsorbed onto enzymes to create a variety of products.

次に本発明の実施例を示す。Next, examples of the present invention will be shown.

太施I111゜ 10 (] +nM IJ 7酸緩衝液(p)16.5
)にNAD+粉末約1[JO//l17’i溶解し4N
KOHでpH@ 6.0にA整した後、そこへ約10,
000単位のI、 D Hを入れ、10℃で10分間反
応ざ+!:た。
Taishi I111゜10 (] +nM IJ 7 acid buffer (p) 16.5
) to dissolve about 1 NAD+ powder [JO//l17'i and 4N
After adjusting the pH to 6.0 with KOH, add it for about 10 minutes.
Add 000 units of I and D H and react at 10°C for 10 minutes! :Ta.

反応液全限外F迦し、F液を集め、LDHの除去され7
’cNAD”を回収する。回収したNAI)+溶液につ
いての分析結果を表1に示した。
The entire reaction solution was subjected to ultraviolet F, the F solution was collected, and LDH was removed.
'cNAD' was collected. The analysis results for the collected NAI)+ solution are shown in Table 1.

尚、NAD+中の阻害物質の含付桿度はつぎの様にして
測定される。
Incidentally, the degree of inclusion of the inhibitory substance in NAD+ is measured as follows.

0、1 MTris−[(Cl(pH8,5) 0.9
0m1.、80mMNAD 4−溶液(、pH8,5)
約8 u /mlウサギ筋肉LDH金キューベントに入
れ、25℃5分間インキュベーションを行う。その後4
0 mM L−乳酸全12d加え、分光光度計を用い2
5℃での1分間当りの吸光度変化fc測測定る。
0,1 MTris-[(Cl(pH8,5) 0.9
0m1. , 80mM NAD 4-solution (pH 8,5)
Approximately 8 u/ml rabbit muscle LDH was placed in a gold cube and incubated at 25° C. for 5 minutes. then 4
Add 12 d of 0 mM L-lactic acid and add 2 d using a spectrophotometer.
Absorbance change per minute at 5°C is measured by fc measurement.

阻害物質を含有していないと思われる標準NAn+での
ΔAO7/ m i nとNAD+サンプルでのΔA 
/ mi nとの比をめ、阻害物質の含有程度を相対活
性と表 1 液状LDHで処理した場合の NAD十の品質 * 1.11M物質全含付したNAD+の処理に使用し
たLDHの絵心金示す。
ΔAO7/min for the standard NAn+ that does not seem to contain inhibitors and ΔA for the NAD+ sample
Table 1 Quality of NAD+ when treated with liquid LDH * Eshinkin of LDH used for treatment of NAD+ containing all 1.11M substances show.

*hイ11+す2 ブロム/アン法で七フrロース30MにLDH3001
n9固定したL D Hゲル3mJiつめたカラムに0
.1 M K −PO,(p)J l O)金流しカラ
ムをモ衡化ざぎる。ついで100 m9.l ml N
A1.)+溶液(pH”10)1mlカラムへ流(2、
その後同じ緩衝液でNAD+を溶出した。
*H11 + S2 LDH3001 to 7 frose 30M using Brom/Anne method
0 to a column packed with 3 mJi of n9-fixed LDH gel.
.. 1M K-PO, (p)JlO) Moisturize the gold flow column. Then 100 m9. l ml N
A1. ) + solution (pH”10) flow into 1 ml column (2,
NAD+ was then eluted with the same buffer.

カラノ・から回収されたNAI)+について、実施例1
と同様に分析を行った。分析結果を表1に示した。
Example 1 Regarding NAI)+ recovered from Carano.
Analyzes were conducted in the same manner. The analysis results are shown in Table 1.

を 2 置屋化1. l) Hで処理した場合のNAI
)+の品質 固定化T、 D Hの給源を示す
2 Establishment of an okiya 1. l) NAI when treated with H
) + quality fixed T, DH indicates the source of H

Claims (2)

【特許請求の範囲】[Claims] (1) NAD+活性阻害物質を含佇するNAD+とN
AD ’−依存性酵素の一種もしくは二種以上とを緩衝
液中で接触させて、NAD’°に含有されるNAD +
活性阻害物質を除去することを特徴とするNAD+活性
阻害物質除去方法。
(1) NAD+ and N containing NAD+ activity inhibitors
By contacting one or more AD'-dependent enzymes in a buffer solution, the NAD + contained in NAD'° is removed.
A method for removing an NAD+ activity inhibitor, which comprises removing an activity inhibitor.
(2) NAD+依存性酵素が固定化されたものである
こと全特徴とする特許請求の範囲第1項記載のNAD+
活性阻害物質除去方法。
(2) NAD+ according to claim 1, which is characterized in that an NAD+-dependent enzyme is immobilized.
Method for removing activity inhibitors.
JP4143684A 1984-03-06 1984-03-06 Removal of nad+ activation inhibitor Granted JPS60186297A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4143684A JPS60186297A (en) 1984-03-06 1984-03-06 Removal of nad+ activation inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4143684A JPS60186297A (en) 1984-03-06 1984-03-06 Removal of nad+ activation inhibitor

Publications (2)

Publication Number Publication Date
JPS60186297A true JPS60186297A (en) 1985-09-21
JPH0452117B2 JPH0452117B2 (en) 1992-08-20

Family

ID=12608318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4143684A Granted JPS60186297A (en) 1984-03-06 1984-03-06 Removal of nad+ activation inhibitor

Country Status (1)

Country Link
JP (1) JPS60186297A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5554894A (en) * 1978-10-13 1980-04-22 Toyobo Co Ltd Novel formaldehyde-dehydrogenase and its preparation
JPS5816873A (en) * 1981-07-23 1983-01-31 Usac Electronics Ind Co Ltd Regulation of stopping position of printing medium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5554894A (en) * 1978-10-13 1980-04-22 Toyobo Co Ltd Novel formaldehyde-dehydrogenase and its preparation
JPS5816873A (en) * 1981-07-23 1983-01-31 Usac Electronics Ind Co Ltd Regulation of stopping position of printing medium

Also Published As

Publication number Publication date
JPH0452117B2 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
US3912588A (en) Creatine amidohydrolase in the conversion of creatinine to creatine
CA1128443A (en) Process for the preparation of l-tryptophan by enzyme
US4064010A (en) Purification of uricase
US4062731A (en) Production of uricase from micrococcus luteus
US4753882A (en) Urease and process for preparation thereof
JPS60186297A (en) Removal of nad+ activation inhibitor
JPS6030679A (en) Preparation of s-adenosyl-l-homocysteine hydrolase
Shoaf III et al. Carbonic anhydrase of microorganisms: I. An enzyme from baker's yeast which catalyzes the formation of carbamate from ammonium bicarbonate solutions
JP2926249B2 (en) Method for producing alginate lyase
JPS6120268B2 (en)
JP2924679B2 (en) Production method of D-lysine
JPH06303995A (en) Method for determining 1,5-anhydroglucitol
JPH0998779A (en) Trehalose synthetase, its production and production of trehalose using the enzyme
SU785318A1 (en) Method of preparing bacterial lucipherase preparate
JPH0466875B2 (en)
JPS62122591A (en) Racemization of optically active 5-substituted hydantoin
JPS6031473B2 (en) Method for producing polyamine oxidases using microorganisms
JPS6332492A (en) Production of levorotatory optically active isomer of mandelic acid by enzymatic process
JPH066075B2 (en) Method for quantifying L-amino acid and α-keto acid
JPH04117281A (en) Production of betaine aldehyde dehydrogenase
JPS61128895A (en) Production of useful substance using coenzyme recovery reaction
JPS6013665B2 (en) Microbial polyamine oxidase AT-1
JPH0240B2 (en)
JPH05176794A (en) Production of optically active 2-phenylpropionic acid and 2-phenylpropionamide
JPH047678B2 (en)